https://www.grafapex.com2026-05-20https://www.grafapex.com/how-to-orderhttps://www.grafapex.com/hubfs/grafapex-5g-bottle.pnggrafapex-5g-bottlegrafapex-5g-bottlehttps://www.grafapex.com/hubfs/GRAFAPEX-Website/thumb-billing-and-coding.jpgthumb-billing-and-codingthumb-billing-and-codinghttps://www.grafapex.com/hubfs/GRAFAPEX-Website/grafapex-1g-bottle.pnggrafapex-1g-bottlegrafapex-1g-bottle2026-05-20https://www.grafapex.com/efficacyhttps://www.grafapex.com/hubfs/icon-gauge.svgicon-gaugeicon-gaugehttps://www.grafapex.com/hubfs/icon-stem-cell.svgicon-stem-cellicon-stem-cellhttps://www.grafapex.com/hubfs/grafapex-kaplan-meier-chart.pngKaplan-Meier chart showing the rate of overall survival since time of randomization for patients on busulfan vs treosulfan.grafapex-kaplan-meier-charthttps://www.grafapex.com/hubfs/icon-people.svgicon-peopleicon-people2026-05-20https://www.grafapex.com/site-map2026-05-20https://www.grafapex.com/resourceshttps://www.grafapex.com/hubfs/GRAFAPEX-Website/thumb-product-overview.pngthumb-product-overviewthumb-product-overviewhttps://www.grafapex.com/hubfs/GRAFAPEX-Website/webp/thumb-billing-and-coding.webpthumb-billing-and-codingthumb-billing-and-codinghttps://www.grafapex.com/hubfs/GRAFAPEX-Website/thumb-dosing-brochure.pngthumb-dosing-brochurethumb-dosing-brochurehttps://www.grafapex.com/hubfs/GRAFAPEX-Website/webp/thumb-grafapex-access-support.webpthumb-grafapex-access-supportthumb-grafapex-access-supporthttps://www.grafapex.com/hubfs/GRAFAPEX-Website/webp/thumb-patient-enrollment.webpthumb-patient-enrollmentthumb-patient-enrollment2026-05-20https://www.grafapex.com/contact-us2026-05-20https://www.grafapex.com/dosing-and-administrationhttps://www.grafapex.com/hubfs/grafapex-10g-m-iv.pnggrafapex-10g-m-ivgrafapex-10g-m-ivhttps://www.grafapex.com/hubfs/icon-vialtime.svgicon-vialtimeicon-vialtimehttps://www.grafapex.com/hubfs/icon-temperature.svgicon-temperatureicon-temperaturehttps://www.grafapex.com/hubfs/grafapex-dosage-regimen.pnggrafapex-dosage-regimengrafapex-dosage-regimen2026-05-20https://www.grafapex.com/home-doahttps://www.grafapex.com/hubfs/GRAFAPEX-Website/grafapex-meta-image.jpggrafapex-meta-imagegrafapex-meta-image2026-05-20https://www.grafapex.com/accessibility2026-05-20https://www.grafapex.com/patient-supporthttps://www.grafapex.com/hubfs/grafapex-copay-card.pngSample GRAFAPEX copay cardgrafapex-copay-cardhttps://www.grafapex.com/hubfs/GRAFAPEX-Website/core-connections-logo.pngcore-connections-logocore-connections-logohttps://www.grafapex.com/hubfs/telephone-support.pngtelephone-supporttelephone-support2026-05-20https://www.grafapex.com/safetyhttps://www.grafapex.com/hubfs/grafapex-adverse-event-table-mobile-ac.pnggrafapex-adverse-event-table-mobile-acgrafapex-adverse-event-table-mobile-achttps://www.grafapex.com/hubfs/grafapex-adverse-event-table-ac.pnggrafapex-adverse-event-table-acgrafapex-adverse-event-table-ac2026-05-20https://www.grafapex.com/terms-of-use2026-05-20https://www.grafapex.com/treating-aml-and-mdshttps://www.grafapex.com/hubfs/GRAFAPEX-Website/grafapex-flower.pnggrafapex-flowergrafapex-flowerhttps://www.grafapex.com/hubfs/icon-people.svgicon-peopleicon-peoplehttps://www.grafapex.com/hubfs/GRAFAPEX-Website/alloHSCT-goals.pngIcons showing the goals of allo-HSCT conditioning: maximizing antileukemic activity, providing durable engraftment, and minimizing toxicity-related effects.alloHSCT-goalshttps://www.grafapex.com/hubfs/icon-calendar.svgicon-calendaricon-calendar2026-05-20